rfkjr-kei-13June2025-xtandi June 13, 2025 Robert F. Kennedy, Jr. Secretary U.S. Department of Health and Human Services 200 Independence Ave SW, Washington, DC 20201 RE: Request for issuance of authorization and consent to use federal rights in three patents to supply… Continue Reading
On June 2, 2025, Knowledge Ecology International (KEI) offered comments to the National Institutes of Health (NIH) regarding the “Prospective Grant of an Exclusive Patent License: c-Abl Tyrosine Kinase Inhibitory Compound Embodiments and Methods of Making and Using the Same”… Continue Reading
On Friday, 30 May 2025, Knowledge Ecology International (KEI) delivered the following statement at the opening of WIPO’s 51st session of the Intergovernmental Committee on Genetic Resources, Traditional Knowledge, and Folklore which meets from 30 May 2025 to 5 June… Continue Reading
On Monday, 19 January 2025,Knowledge Ecology International (KEI) delivered this constituency statement on behalf of KEI, Health Action International, Oxfam, World Blind Union, and World Council of Churches on the following topic: Intergovernmental Negotiating Body to draft and negotiate a… Continue Reading
On May 7, 2025, Knowledge Ecology International (KEI) submitted comments to the National Institutes of Health (NIH) regarding the “Prospective Grant of an Exclusive Patent License: Size-Dependent Brain and Lymphatic Distribution of Macromolecular Drug Delivery Platform” (90 FR 16878) to… Continue Reading
On Thursday, 22 May 2025, Knowledge Ecology International (KEI) will convene a side event entitled, “Workplan for WHO and member states to improve the Transparency of the Value Chain for Biomedical Products”. The panel will take place in the Henry… Continue Reading
In recent discussions at the 34th session World Intellectual Property Organization’s (WIPO) Committee on Development and Intellectual Property (CDIP), the United States of America expressed its antipathy to WIPO’s engagement with the Sustainable Development Goals (SDGs). The United States expressed… Continue Reading
Cost of initial risdiplam trials The cost of trials used to support the initial FDA approval of risdiplam (Evrysdi) KEI Research Note 2025:2 James Packard Love April 23, 2025
On Wednesday morning, 9:03 CEST, the World Health Organization (WHO) circulated the Proposal for the WHO Pandemic Agreement, ONSCREEN text reflecting progress up to Wednesday, 16 April 2025 at 01:57 CEST, to non-State actors in official relations with the World… Continue Reading
This is the pandemic agreement text, as of today. Negotiations are resumed Tuesday, but this is what people expect to be in the fine agreement. Green is supposed to mean the text is final. The EU still not in agreement… Continue Reading